跳到正文
Molence· @MolenceBio · X·· 17 天前AI 评分53
AI 导读

Molence Bio 分享的 VHH 设计结果显示,30 个设计中 5 个在以 VHH-Fc 融合形式测试时能同时结合两种非直系同源细胞因子。这两种细胞因子的无空位序列一致性为 54%,同一批设计对细胞因子-A 和细胞因子-B 分别得到 11 个和 7 个结合命中。作者据此提出,双抗原识别可以作为设计流程中的一个明确目标。

正文 · 原文

8/15 🎯 One VHH, two antigens—by design.

We designed VHHs to recognize two non-orthologous cytokines sharing 54% ungapped sequence identity.

Five of 30 designs bound both antigens when tested as VHH-Fc fusions. The same design set yielded 11 hits against cytokine-A and 7 against cytokine-B.

Dual-antigen recognition can be an explicit objective in the design workflow.

#ProteinDesign

引用Molence@MolenceBio
7/15 🧬 A designed VHH can antagonize a GPCR. The CXCR6 design bound receptor-expressing cells with an EC50 of 39 nM, tested as a VHH-Fc fusion. In the cAMP assay, 30 nM CXCL16 reduced the response to 70.6% of the forskolin-only control. Adding 167 nM VHH restored it to 92.6%. This experiment supports antagonism of CXCL16-induced CXCR6 signaling by a computationally designed binder. #DrugDiscovery
在 X 查看被引用的帖子

来源:Molence · x.com